Related by context. All words. (Click for frequent words.) 80 Previously Treated 80 Improves Outcomes 79 Metastatic Prostate Cancer 79 Improves Survival 79 Renal Cell Carcinoma 79 Survival Benefit 79 Advanced Melanoma 79 Castration Resistant Prostate Cancer 79 Pooled Analysis 78 Antitumor Activity 78 Phase 2b Clinical Trial 78 Meets Primary Endpoint 78 Phase III Clinical Trial 78 Newly Diagnosed Multiple Myeloma 78 Treatment Experienced 78 Metastatic Renal Cell Carcinoma 78 Patients Treated With 77 Resistant Hypertension 77 Patients Treated 77 Myeloma Patients 77 Study Showed 77 Colorectal Cancer Patients 77 Advanced Prostate Cancer 77 Hormone Refractory Prostate Cancer 77 Elderly Patients 77 Is Well Tolerated 76 Oral Fingolimod 76 Relapsing Remitting Multiple Sclerosis 76 Clinical Trial Results 76 Rheumatoid Arthritis Patients 76 Trial Evaluating 76 Subgroup Analysis 76 Combination REOLYSIN R 76 Previously Untreated 76 Treatment Naive Patients 76 Metastatic Colorectal Cancer 76 Prolongs Survival 76 II Clinical Trial 76 Appears Safe 75 HER2 Positive Breast Cancer 75 Advanced Colorectal Cancer 75 Study Evaluating 75 Advanced Ovarian Cancer 75 Relapsed Refractory 75 Monotherapy 75 Randomized Phase 75 Relapsing Multiple Sclerosis 75 Renal Impairment 75 Shows Efficacy 75 Pivotal Phase 75 Adjuvant Treatment 75 Phase III Trial 75 Patients Receiving 75 Long Term Efficacy 75 Drug Combo 75 Dose Escalation 75 Improved Survival 75 Patient Enrollment 75 Phase 2a Trial 75 Shows Promising 75 Significantly Reduced 75 Inhaled Corticosteroids 75 Chronic Hepatitis C 75 Prostate Cancer Patients 75 Phase 2b Trial 74 Refractory Hodgkin Lymphoma 74 Lung Cancer Patients 74 Phase IIb Trial 74 Lowers Risk 74 Randomized Phase II 74 Completes Patient Enrollment 74 Statistically Significant 74 Critically Ill Patients 74 Drug Shows Promise 74 Unfractionated Heparin 74 Demonstrate Significant 74 Study Shows Promise 74 Advanced Solid Tumors 74 Anti Tumor Activity 74 Adjuvant Chemotherapy 74 HCV Protease Inhibitor 74 Ovarian Cancer Patients 74 Phase III Trials 74 Randomized Double Blind 74 Patients Undergoing 74 Hormone Receptor Positive 74 Slow Progression 74 Carboplatin Paclitaxel 74 Well Tolerated 74 Phase 2a Clinical Trial 74 Metastatic Pancreatic Cancer 74 Treatment Reduces 74 Disease Progression 74 Demonstrates Positive 74 Pivotal Study 73 Lung Cancer Survival 73 Treatment Shows Promise 73 Relapsed Refractory Multiple Myeloma 73 Slows Progression 73 Randomized Trials 73 Spectrum Pharmaceuticals Announces 73 Improve Survival 73 Clinical Trial Evaluating 73 Adjunctive Therapy 73 Gentium Announces 73 Initiate Phase III 73 Radical Prostatectomy 73 Cardiac Resynchronization 73 Pivotal Phase III 73 Bare Metal Stents 73 Paclitaxel Carboplatin 73 Cholesterol Lowering Drug 73 Predict Risk 73 Treated Patients 73 Patients Enrolled 73 Node Positive 73 Cardiovascular Events 73 Therapy Improves 73 Investigational Compound 73 First Patient Enrolled 73 Single Dose 73 Investigational Treatment 73 Combination Treatment 73 Osteoporosis Drugs 73 Hypertensive Patients 73 Demonstrated Significant 73 Ischemic Stroke 73 Artery Disease 73 Chemotherapy Improves 73 Patients Suffering 73 Multiple Myeloma Patients 73 Knee Osteoarthritis 73 Antidepressants Linked 72 Statin Therapy 72 Drug Candidate 72 Breast Cancer Recurrence 72 Drug Prevents 72 Combo Therapy 72 Investigational Drug 72 Premenopausal Women 72 Poorly Controlled 72 Advanced Renal Cell 72 Autologous Stem Cell Transplantation 72 Immunomedics Announces 72 FDA Approves Drug 72 Sustained Reduction 72 Atypical Hemolytic Uremic Syndrome 72 Preclinical Data 72 Newly Diagnosed Patients 72 Chronic Myeloid Leukemia 72 Phase 2b Study 72 Controlled Trial 72 bone marrow reticulin deposition 72 Fewer Side Effects 72 Hematological Cancers 72 ST Elevation Myocardial 72 Desvenlafaxine Succinate 72 Commonly Prescribed 72 Heart Failure Patients 72 Often Misdiagnosed 72 Severe Sepsis 72 Chronic Constipation 72 Lung Cancer Trial 72 Treatment Resistant 72 Bone Marrow Cells 72 Bone Fracture 72 Metastatic Melanoma 72 Disease Modifying 72 Cutaneous T 72 Treatment Naïve 72 Randomized Clinical Trials 72 Significantly Improved 72 Myelodysplastic Syndromes 72 Phase IIb Clinical Trial 72 Adjuvant Therapy 72 Epilepsy Drug 72 Anti Tumor 72 Brentuximab Vedotin SGN 72 Shows Promise Against 72 Dose Ranging 72 Gout Drug 72 Kidney Transplant Patients 72 R Bortezomib 72 Chemoradiation 72 Nicotine Vaccine 72 Newly Diagnosed Breast Cancer 72 Lupus Nephritis 72 Sleep Disturbances 72 Versus Placebo 72 Naive Patients 72 HER2 Positive 72 Successfully Treated 72 Proves Effective 72 Osteoporosis Drug 72 Cholesterol Drugs 72 Carotid Stenting 72 Gene Variant 72 Pediatric Patients 72 Breast Cancer Treatment 72 Gene Linked 72 Overactive Bladder 72 Glycemic Control 72 Bone Metastases 71 Blood Pressure Drugs 71 Glufosfamide 71 Novel Oral 71 Demonstrates Significant 71 Acute Ischemic Stroke 71 Genes Linked 71 Obese Patients 71 Androgen Deprivation Therapy 71 Phase 1b Clinical Trial 71 EntreMed Presents 71 Topline Results 71 Kidney Transplants 71 Liver Failure 71 Double Blind Placebo 71 FDA Okays 71 Stent Restenosis 71 Chronic Hepatitis B 71 Obesity Linked 71 evaluating tivozanib 71 Pivotal Trial 71 Telik Announces 71 Postmenopausal Osteoporosis 71 Complicated Skin 71 Treating Chronic 71 Genes Predict 71 Smoking Linked 71 Completes Enrollment 71 Anthracycline 71 Treatment Naive 71 Peginterferon 71 Oral Laquinimod 71 Multicenter Trial 71 Clot Busting 71 Limb Ischemia 71 Demonstrates Efficacy 71 Anticancer Drugs 71 Multicenter Randomized 71 Biogen Genentech 71 Pivotal Clinical Trial 71 Pivotal Trials 71 Osteoarthritis Patients 71 Randomized Study 71 Fracture Risk 71 Perifosine KRX 71 Advanced Pancreatic Cancer 71 JAK Inhibitor 71 Hsp# Inhibitor 71 Plus Ribavirin 71 achieved CCyR 71 Showed Significant 71 Significant Reduction 71 Pulmonary Arterial Hypertension 71 FDA Approves Novel 71 Newly Diagnosed 71 Serious Infections 71 Prospective Randomized 71 Treat Heart Failure 71 Statin Drugs 71 Left Ventricular Hypertrophy 71 Gastric Cancer 71 Levels Linked 71 Investigational Agent 71 Treat Anemia 71 Partial Onset Seizures 71 acute peptic ulcer 71 concomitant cardiac 71 Phase III Pivotal Trial 71 Chronic Sinusitis 71 Soft Tissue Sarcoma 71 Sangamo BioSciences Announces 71 Commonly Used 71 Acute Heart Failure 71 Long Term Survival 70 Lung Cancer Drug 70 Gene Variation 70 Schizophrenia Drug 70 Transplant Patients 70 Venous Thromboembolism 70 Tumor Growth 70 Drug Fails 70 Follicular Lymphoma 70 Fungal Infections 70 Gene Mutation Linked 70 Randomized Phase III 70 Renal Cancer 70 Novel Antibiotic 70 NICE Recommends 70 Effective Than 70 Heartburn Drugs 70 Rectal Cancer 70 Plaque Psoriasis 70 Diabetic Patients 70 Mouse Model 70 Blood Pressure Drug 70 Complete Remission 70 Epratuzumab 70 Pharmacyclics Announces 70 Endometrial Cancer 70 Phase IIa Clinical Trial 70 Achieves Primary Endpoint 70 Bipolar Depression 70 Anemia Drug 70 B Cell Malignancies 70 Randomized Controlled Trials 70 Brain Metastases 70 CYT# potent vascular disrupting 70 Initiate Phase 70 Active Rheumatoid Arthritis 70 Malignant Glioma 70 Antipsychotic Drugs 70 Nesiritide 70 Arthritis Drug 70 Mylan Receives Approval 70 Anticancer Activity 70 Cardiovascular Outcomes 70 Cholesterol Levels 70 Acute Exacerbations 70 Chronic Lymphocytic Leukemia 70 Zoledronic Acid 70 Hepatitis C Genotype 70 Anti Clotting Drug 70 Tolerability 70 ACE Inhibitors 70 Lupus Drug 70 Localized Prostate Cancer 70 Tiotropium 70 Patient Outcomes 70 Valvular Heart Disease 70 Allergic Rhinitis 70 Boosts Survival 70 Atypical Antipsychotics 70 Acute Migraine 70 Presents Positive 70 Secondary Hyperparathyroidism 70 PRN FDA Approves 70 Newly Diagnosed Chronic Myeloid 70 Sapacitabine 70 Reduces Mortality 70 Unresectable 70 Demonstrates Potent 70 Spinal Fractures 70 Peginterferon Alfa 2a 70 ACTEMRA TM 70 Placebo Controlled Trial 70 Oral Calcitonin 70 Epoetin Alfa 70 Malignant Melanoma 70 Demonstrates Sustained 70 Randomized Double blind 70 Drug Coated Stents 70 Efficacy Trial 70 Postmenopausal Women 70 Randomized Clinical Trial 70 Enlarged Prostate 70 Hepatitis C Patients 70 Significantly Improves 70 Granted Orphan Drug 70 Physical Function 70 Bone Fractures 70 Hemodialysis Patients 70 CYPHER R Sirolimus Eluting 70 Rheumatoid Arthritis Drug 70 Stem Cell Treatment 70 Study Demonstrates 70 Chronic HCV 70 Statistically Significant Improvement 70 Increased Risk 70 Confirmatory Phase 70 Treating Heart Failure 69 Antipsychotic Medications 69 Migraine Headaches 69 Capsules CII 69 Effectively Treats 69 Successfully Treats 69 Pharmacokinetic Study 69 Asthma Symptoms 69 Blood Thinner 69 Increases Risk 69 Severely Obese 69 NPS Pharmaceuticals Announces 69 Study Shows Benefits 69 Renal Function 69 Septic Shock 69 Cervical Dysplasia 69 Rotavirus Vaccine 69 Fixed Dose 69 Initiates Phase III 69 Experimental Vaccine 69 Asthma Treatment 69 Reduced Risk 69 Vicriviroc 69 Antidepressant Use 69 Recurrent Breast Cancer 69 Drug Resistant 69 Seasonal Allergic Rhinitis 69 First Patient Dosed 69 Breast Cancer Patients 69 Prostate Cancer Recurrence 69 Liver Metastases 69 Depressive Symptoms 69 Vaccine Prevents 69 Controlled Study 69 Stable Coronary Artery 69 Sustained Efficacy 69 Platelet Inhibition 69 Clinical Outcome 69 Hospital Acquired Pneumonia 69 Brain Atrophy 69 Stomach Cancer 69 Infected Patients 69 NDA Submission 69 Prolongs Life 69 Viral Suppression 69 Vitamin D Linked 69 Diabetic Nephropathy 69 Therapy Reduces 69 Poniard Pharmaceuticals Announces 69 Survival Rates 69 Lowering Blood Pressure 69 Less Invasive 69 Blood Clots 69 Lung Cancers 69 Nymox NX 69 Stent Implantation 69 Nilotinib 69 Reduces Pain 69 SPRYCEL ® 69 Kidney Function 69 Liver Tumors 69 Renal Cell Cancer 69 Golimumab 69 Gene Mutation 69 Recurrent Ovarian Cancer 69 Recurrent Glioblastoma 69 moderate renal impairment 69 Natalizumab 69 Dose Finding 69 Romiplostim 69 Preterm Delivery 69 Prophylactic Treatment 69 See CLINICAL PHARMACOLOGY 69 Stem Cell Transplants 69 Orally Active 69 Post Operative 69 Premature Infants 69 Colorectal Adenomas 69 Bone Marrow Transplants 69 Cognitive Decline 69 Balloon Angioplasty 69 Eases Pain 69 Clostridium difficile Infection 69 Aflibercept 69 Blood Clot Risk 69 Therapeutic Efficacy 69 Prostate Tumors 69 Gastrointestinal Stromal Tumors 69 Bipolar Mania 69 Increased Mortality 69 Long Term Outcomes 69 Preclinical Study 69 Systemic Sclerosis 69 Heterozygous Familial Hypercholesterolemia 69 Emerging Therapies 69 Patient Treated 69 Elotuzumab 69 Shown Effective 69 Prostate Cancer Vaccine 69 Reduces Risk 69 Vaccine Adjuvant 69 Late Breaker 69 humanized interleukin 6 69 Cholesterol Drug 69 Acute Myocardial Infarction 69 Prostate Biopsy 69 Vildagliptin 69 Menopausal Women 69 Solid Tumors 68 Multicenter Phase 68 Unstable Angina Non 68 Glatiramer Acetate 68 Stent Thrombosis 68 Previously Untreated Multiple Myeloma 68 Antibody Drug Conjugate 68 Bivalirudin 68 Mg Usa 68 Arthritis Sufferers 68 Intra Arterial 68 Gene Therapy Trial 68 Diffuse Large B 68 Beta Blockers 68 Dasatinib 68 Oral Anticoagulant 68 Clinical Efficacy 68 Tipranavir 68 Bevacizumab 68 INSPIRE Trial Phase III 68 AVI BioPharma Announces 68 Phase III Pivotal 68 JAK2 Inhibitor 68 Moderate Drinking 68 Antidepressant Drug 68 Inhaled Nitric Oxide 68 Diabetic Neuropathic Pain 68 R lenalidomide 68 Severe Asthma 68 Teva Provides Update 68 Cancer Patients Treated 68 relapsed MM 68 Androgen Deprivation 68 Meta Analysis 68 Acute Coronary Syndromes 68 Initiates Clinical Trial 68 Inhaled Insulin 68 Antitumor 68 novel orally inhaled 68 Osteoporosis Treatment 68 Idenix Pharmaceuticals Reports 68 Investigational Oral 68 Data Suggest 68 Fibromyalgia Pain 68 Decompensated Heart Failure 68 MEK Inhibitor 68 Neoadjuvant Chemotherapy 68 Test Detects 68 Transdermal Patch 68 Guidelines Issued 68 Million Cribs Recalled 68 Own Stem Cells 68 Genetic Variant 68 Significant Improvement 68 Lymph Nodes 68 FDA Panel Recommends 68 Aspirin Reduces 68 Prostate Cancer Treatment 68 Chronic Heart Failure 68 Receives Positive Opinion 68 CYP#A# substrate 68 Lung Transplants 68 Gastric Ulcers 68 Blood Thinning 68 Beneficial Effects 68 Endothelial Function 68 Primary Hypercholesterolemia 68 Sipuleucel T 68 Initiates Enrollment 68 Protease Inhibitor 68 Second Pivotal Phase 68 Tyrosine Kinase Inhibitor 68 Humanized Anti 68 Breast Cancers 68 Protein Linked 68 Novel Mechanism 68 Colorectal Cancers 68 R# #mg BID 68 Epilepsy Drugs 68 Initiates Phase II 68 novel VDA molecule 68 Randomized Double Blind Placebo 68 Aggressive Prostate Cancer 68 Fulvestrant 68 Vaccine Protects Against 68 Virus Linked 68 Certain Cancers 68 Cell Transplants 68 Suffer Depression 68 Significantly Reduces 68 Pulmonary Artery 68 Juvenile Idiopathic Arthritis 68 Helps Relieve 68 Pegylated Interferon 68 BioElectronics Announces 68 Skeletal Muscle 68 Cognitive Function 68 Certolizumab 68 Cancer Recurrence 68 Improve Outcomes 68 Onyx Pharmaceuticals Announces 68 Uterine Fibroid Embolization 68 Submits NDA 68 Benign Prostatic Hyperplasia 68 Hematological Malignancies 68 Nebulized 68 intravesical infusion therapy 68 Randomised Trial 68 Receives Orphan Drug Designation 68 Placebo Controlled 68 Blocked Arteries 68 Fondaparinux 68 First Patient Treated 68 Ventricular Arrhythmias 68 Synta Announces 68 Etanercept 68 Pre Cancerous 68 myocardial infarction ventricular fibrillation 68 Healthbeat Report 67 Calcium Vitamin D 67 Kidney Transplant Recipients 67 Cardiovascular Mortality 67 Primary Endpoint 67 Immunosuppression 67 Predict Prostate Cancer 67 Inflammatory Markers 67 Osteoarthritis Knee Pain 67 Seasonal Allergies 67 Brain Scans 67 Medullary Thyroid Cancer 67 ST Segment Elevation 67 Confirms Efficacy 67 Mayo Clinic Study Finds 67 Clinical Trial Data 67 ARIXTRA R 67 Genes Identified 67 Treatment Naive HIV 67 Neovascular Age Related Macular 67 Safinamide 67 Therapy Shows Promise 67 Potentially Fatal 67 Rigel R# 67 Enzo Biochem Reports 67 Migraine Drug 67 Eszopiclone 67 Cocaine Addiction 67 Higher Doses 67 Diabetic Foot Ulcer 67 Chronic Cough 67 RNAi Therapeutic 67 evaluating mipomersen 67 Myocardial Ischemia 67 Diabetic Kidney Disease 67 Known hypersensitivity 67 Pharmacokinetics PK 67 Randomized Controlled 67 Ameris Bancorp Reports 67 Antifungals 67 Insulin Glargine 67 metastatic castration resistant 67 Statin Use 67 PEGylated Fab fragment 67 Anticancer Drug 67 brand ciclesonide HFA 67 alfa 2a 67 Skin Lesions 67 Cell Lymphoma 67 Potent Antiviral Activity 67 Ovary Removal 67 Strongly Linked 67 FDA Approvals 67 Prevent Fractures 67 FOLFOX6 67 rash pruritus nausea 67 Telik logo TELINTRA 67 Lung Cancer Risk 67 Folic Acid Supplements 67 Recurrent Stroke 67 Phase III Clinical Trials 67 Laryngeal Cancer 67 Testosterone Levels 67 Genes Associated 67 Begins Dosing 67 Telithromycin 67 Multicenter Randomized Double 67 Eculizumab 67 Nuvelo Announces 67 Nerve Pain 67 Stereotactic Body Radiation Therapy 67 Initiated Phase 67 Prostate Cancer Survival 67 Cardiotoxicity 67 Gemzar ® 67 Adalimumab 67 Unstable Angina 67 Progressive Multifocal Leukoencephalopathy 67 Kidney Failure 67 Breast Cancer Tumors 67 Dementia Patients 67 moderate hepatic impairment 67 Aeolus Pharmaceuticals Announces 67 Interferon Beta 67 Heart Transplant Recipients 67 Organ Rejection 67 Clot Risk 67 Clinically Significant 67 Treatment Regimen 67 Schiavo Autopsy 67 infliximab monotherapy 67 stage IIIb IV 67 Diamyd Medical Diamyd 67 Severe Psoriasis 67 Peginterferon Alfa 2b 67 BRIM2 67 Cognitive Impairment 67 Ovarian Cancer Treatment 67 Lung Function 67 Presents Preclinical Data 67 Overweight Obese 67 metaglidasen 67 ® lenalidomide 67 Visceral Fat 67 Total Knee Arthroplasty 67 Respiratory Distress 67 Chronic Renal Failure 67 Calcium Supplements 67 Epidermal Growth Factor Receptor 67 Xelox 67 Relapsed Refractory Aggressive 67 Hepatitis C Infection 67 Injection Site 67 8mg/kg 67 recurrent metastatic ovarian cancer 67 Combination Therapy 67 Dose Ranging Study 67 TO AVOID PREGNANCY WHILE 67 Stem Cells Used 67 Accelr8 Announces 67 Mesothelioma Treatment 67 Migraine Headache 67 Breathing Problems 67 Randomized Controlled Trial 67 Renal Anemia 67 Medoxomil 67 Threshold Pharmaceuticals Announces 67 dasatinib Sprycel ® 67 Cyclophosphamide 67 Pregnancy Linked 67 Thromboembolic 67 Chronic Liver Disease 67 Atypical Antipsychotic 67 MRSA Infections 67 metastatic ocular 67 Adjunctive Treatment 67 Antipsychotic Drug 67 Blood Cancers 67 Psoriasis Drug 67 Antiplatelet Therapy 67 BARACLUDE R 67 Breast Tumors 67 Placebo Controlled Study 67 evaluating picoplatin 67 Pegylated Liposomal Doxorubicin 67 Menstrual Cramps 67 Thyroid Hormone 67 Symptom Improvement 67 Hepatocellular Carcinoma HCC 67 dapagliflozin plus 67 Capecitabine 67 CYP#A# CYP#D# 67 mitoxantrone plus 67 Ranolazine 67 Vaccine Candidate 67 Mg Uk 67 Bosutinib 67 Lower Blood Pressure 67 Hedgehog Pathway 67 Mycophenolate Mofetil 66 Hyperlipidemia 66 ORLive Presents 66 FUSILEV enhances 66 Seasonal Influenza Vaccine 66 Transplant Rejection 66 Treating Depression 66 Chemotherapy Regimen 66 Present Preclinical Data 66 Crofelemer budesonide foam 66 Vaccine Shows Promise 66 Tezampanel 66 de novo kidney transplant 66 Non Responders 66 Helps Smokers Quit 66 Rare Genetic 66 Inhaled Steroids 66 Improves Quality 66 Breast Density 66 pralatrexate injection folate analogue 66 FDA APPROVES 66 BARACLUDE ® 66 Successfully Completes Phase 66 Vasomotor Symptoms 66 Initiate Clinical Trial 66 Romidepsin 66 Novel Compounds 66 Anemia Drugs 66 Files IND 66 Osteoporotic 66 Crowflight Announces 66 Kaydon Corporation Announces 66 Drug Eluting 66 Demonstrates Potential 66 Research www. elsevier.com 66 Hormone Therapy 66 Vaginal Gel 66 Dementia Related Psychosis 66 Dialysis Patients 66 Genetic Mutations 66 Decitabine 66 Positive Opinion 66 Chronic Stress 66 Prove Effective 66 Guidelines Recommend 66 Surgical Procedures 66 Intravitreal 66 Collaborators Present 66 Expanded Indication 66 LymphoStat B belimumab 66 Multicenter Double 66 Antibiotic Treatment 66 Randomized Placebo Controlled Trial 66 Vertebral Fractures 66 Molecular Diagnostic Test 66 Azacitidine 66 Diuretic 66 Liver Injury 66 Predict Response 66 Oral Cladribine 66 Metabolic Disorder 66 Milestone Payment 66 Chronic Insomnia 66 Genetic Variations 66 Blood Pressure Lowering 66 undergoing elective percutaneous 66 Intracerebral Hemorrhage 66 Bortezomib 66 Hypercholesterolemia 66 HPV Infection 66 Budesonide foam crofelemer 66 NMDA Receptor 66 Comorbidities 66 Corticosteroid 66 Wrestling Wrap Up 66 Albuferon TM 66 Free Survival PFS 66 EOquin TM phase 66 Hip Fractures 66 Renal Artery 66 recurrent glioblastoma multiforme 66 Nucleoside 66 Liver Toxicity 66 Invasive Breast Cancer 66 VIVUS Qnexa 66 relapsing remitting MS RRMS 66 Refractory Angina 66 comparing alemtuzumab 66 Brain Tumor Patients 66 Multicenter Study 66 Pain Relievers 66 Recurrent Prostate Cancer 66 Antiviral Activity 66 Cancer Treatments 66 Blind Placebo Controlled Trial 66 Kidney Tumors 66 Enrolls First 66 Drug Resistant TB 66 Symptom Relief 66 FOLFOX6 chemotherapy regimen 66 Regimens 66 Fast Track Status 66 carcinoma mCRC 66 Pirfenidone 66 Treatment Naïve Patients 66 Phase III AFFIRM 66 ER Visits 66 Blind Placebo Controlled 66 Fluorouracil 66 Advaxis Phase 66 Barr Receives Approval 66 Salix Pharmaceuticals Announces 66 Submits Biologics License Application 66 Ozarelix 66 Diabetic Neuropathy 66 Spinal Fusion 66 Cause Mortality 66 5 fluorouracil leucovorin 66 Drug Coated Stent 66 dependent kinase inhibitor 66 dual endothelin receptor antagonist 66 Reduce Mortality 66 TLUS 66 Recombinant Human 66 FDA Accepts 66 Pneumococcal Vaccine 66 Bladder Cancer 66 Genetic Variants 66 Viral Load 66 CIMZIA ™ 66 Diabetic Macular Edema 66 Shingles Vaccine 66 Anticoagulant 66 MERIT ES 66 Generic Version 66 Belimumab 66 Rheumatoid Arthritis RA 66 Drug Maker 66 Acute Decompensated Heart Failure 66 Testosterone Patch 66 CTAP# Capsules 66 #rd Annual CTRC 66 Fludarabine 66 undergoing Percutaneous Coronary 66 Tumor Response 66 Aliskiren 66 Physician Insights 66 Abiraterone Acetate 66 aplastic anemia AA 66 AirBoss Announces 66 Lung Cancer Vaccine 66 Autoimmune Disease 66 Contrast Agents 66 Arthritis Drugs 66 Peptic Ulcer 66 Genetic Defect 66 Antiangiogenic 66 Abdominal Pain 66 interferon gamma 1b 66 Sirolimus Eluting Stent 66 ORENCIA ® 66 VEGFR2 inhibitor 66 Gene Variants 66 Biologic Therapy 66 neutropenia dehydration dyspnea 66 Efficacious 66 Vitamin D Levels 66 Dendritic Cells 66 Study Compares 66 Boceprevir 66 Generalized Anxiety Disorder 66 CML CP 66 CIMZIA R 66 Ischemic 66 Vertebral Compression Fractures 66 By JENNIFER LEARN 66 Bayer HealthCare Onyx Pharmaceuticals 66 Lung Transplant Patients 66 ZACTIMA TM ZD# 66 Gene Mutations 66 Help Predict 66 azilsartan medoxomil 66 Watchful Waiting 66 Metastatic Breast Cancer 66 KRN# 66 Non Invasive Treatment 66 Muscle Function 66 Shows Promise 66 Relieves Pain 66 Generic Versions 66 Prevent Stroke 66 Bare Metal Stent 66 Antiplatelet 66 Randomized Evaluation 66 Completes Patient Enrolment 66 Lung Cancer Surgery 66 Transplant Recipient 66 Postmenopausal 66 HDAC Inhibitor 66 Predict Breast Cancer 66 Hepatitis C Treatment 66 Derma Sciences Announces 66 multicenter multinational 66 AA Amyloidosis 66 Hepatocellular Carcinoma 66 Obese Teens 66 Aurora Kinase 66 Novel Compound 66 receiving XGEVA 66 Leukemias 66 Paraplatin ® 66 Orphan Diseases 66 Liver Transplants 66 Combination Clinical Trial 66 receiving immunosuppressive therapy 66 Relapsed 66 serum phosphorous 65 Weight Loss Drug 65 Antipsychotic 65 Colorectal Cancer Risk 65 Immune Responses 65 Advanced Gastric Cancer 65 Amrubicin 65 Phase 2a Study 65 Reveals Positive 65 Ribavirin causes 65 Neoadjuvant 65 Earns Milestone Payment 65 R rilonacept Injection 65 TNF Blockers 65 Bone Mineral Density 65 Preclinical Efficacy 65 Cholesterol Levels SPARCL 65 Antiviral Drugs 65 receiving VELCADE 65 Flu Strains 65 Breast Carcinoma 65 Carotid Endarterectomy 65 Lung Infection 65 Paroxysmal Nocturnal Hemoglobinuria PNH 65 Shows Statistically Significant 65 Ovarian Cancer Risk 65 Subtypes